Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest ...

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

In a notable move, Hims & Hers Health donated $1 million to President-elect Donald Trump's inauguration fund, signaling its ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.67 which represents a slight increase of $0.77 or 2.86% from the prior close of $26.9. The stock opened at $27.68 and ...